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Influenza virus constantly escapes antibody inhibition by introducing mutations that disrupt protein–protein interactions. Based on the
structure of the complex between neuraminidase (NA) of influenza A/Memphis/31/98 (H3N2) and the Fab of a monoclonal antibody (Mem5) that
binds and inhibits the Memphis/98 NA, we investigated the contribution made by individual amino acids of NA to the stability of the complex. We
made mutations D147A, D147N, H150A, H197A, D198A, D198N, E199A, E199Q, K221R, A246K, D251N, and D251A. Binding of each
mutant to NAwas quantitated by NA inhibition assays and ELISA. Most of the mutant NAs were inhibited by Mem5 to the same extent as wild-
type, but with lower affinity. The exceptions were E199A, E199Q, and K221R, in which binding was abrogated. The ELISA results confirmed a
correlation between NA inhibition and binding. The Mem5 epitope is dominated by a few high-energy interactions as was found in the epitope on
an avian subtype N9 NA that binds antibody NC41 and different to the more diffuse energy distribution in the NC10 epitope on N9 NA. Energetic
dominance of a particular interaction, which is associated with potential for antibody escape mutations, may be associated with the absence of
water molecules in the vicinity. Critical contacts in a dominant antigenic site are likely to mutate, allowing some predictions of antigenic drift.
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Influenza is a major disease and a leading cause of death in
the United States, with infants, immunosuppressed persons,
and the elderly especially susceptible. The vaccine is safe and
often effective but needs to be updated every year because of
antigenic drift. Influenza virus has two major surface glyco-
proteins protruding from the viral membrane, hemagglutinin
(HA) and neuraminidase (NA). Hemagglutinin binds to sialic
acid receptors, while neuraminidase cleaves sialic acid from the
progeny virions and cell surface and so allows the release and
spread of virus (Liu et al., 1995; Palese et al., 1974). The RNA
polymerase of influenza has a high error rate and, under0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
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Norman, OK, USA.antibody selection, these two surface glycoproteins rapidly
accumulate mutations. Thus, there is a need every year to
reformulate vaccines against influenza. Neutralizing antibodies
directed against HA mostly prevent HA from interacting with
sialic acid receptors (Bizebard et al., 1995; Fleury et al., 1999;
Wiley et al., 1981). Antibodies against NA, while not inhibiting
virus entry, prevent spread of the virus and so protect against
challenge with the same or similar virus (Webster et al., 1988).
NA is a tetramer of identical subunits anchored in the lipid
bilayer by a hydrophobic amino terminal sequence and raised
above the membrane by a variable ‘‘stalk’’ domain (reviewed in
Air and Laver, 1989). Each monomer of the box-shaped 4-fold
symmetric head domain consists of six four-stranded anti-
parallel h-sheets arranged in a propeller fashion (Varghese et
al., 1983). The active site of the enzyme is located in a crater on
top of each monomer.
To understand the nature of the interacting forces between
antigen and antibody, we have previously studied N9 NA
because the only crystal structures that were available of NA–
antibody complexes were of A/tern/Australia/G70c/75 (N9)6) 424 – 433
www.e
Table 1
Design of mutations in Mem/98 NA
Mutant Role of amino acid Rationale for mutation
D147A/Na Forms a salt link with Mem5 Fab H chain (K52B, N~). Ala removes charged side chain.
Asn replaces charged carboxylate
with polar amide group.
H150A Probably forms a salt bridge with Fab H chain (D31, Oy1).
The interaction with a negatively charged group suggests the
His imidazole N atoms are at least partially charged at pH 7.
Removes potential for charge interaction.
H197A Forms a van der Waals contact with Fab H chain (N53).
Forms water-mediated hydrogen bonds to Fab H chain.
Mutagenesis done to see if binding is
dependent on van der Waals contact.
Removes bulky side chain
D198A/N Almost forms two hydrogen bonds with Fab H chain
(N52A, Ny2 and N53, Ny2), but they are long (both 3.5 A˚).
Forms water-mediated hydrogen bonds to Fab H chain.
Ala removes charged side chain.
Asn replaces carboxylate with amide group.
E199A/Q Forms two hydrogen bonds with Fab H chain
(Y33, OH and R52, Ne) and one with L chain (Y94, OH).
Also forms salt bridge with Fab H chain (R52, ND2).
Ala removes charged side chain.
Gln replaces charged carboxylate
with amide group.
K221R Forms several hydrogen bonds with the
H (T99, Og and N100, Oy1) and L chain (Y49, O),
also van der Waals contacts with L chain.
Retains the same charge and hydrogen
bonding potential but introduces shorter,
bulkier side chain.
A246K No side chain interactions. Introduces a long aliphatic, charged side
chain close to antibody H chain.
D251A/N Forms hydrogen bond with Fab L chain (Y53, OH)
and water-mediated hydrogen bonds to Fab L chain.
Ala removes charged side chain.
Asn replaces carboxylate with amide group.
a Mutants are named as the one letter code for the wild-type amino acid followed by the residue number then the substituted amino acid(s). The interactions
described all involve side chain atoms.
Fig. 1. Inhibition of wild-type and mutant NA activity by antibody Mem5. Cell
lysate aliquots containing approximately 1 A549 of NA activity were
preincubated with varying amounts of antibody. Enzyme activity was then
measured using fetuin as substrate. Multiple experiments were averaged.
Results are plotted as percent inhibition of NA activity.
J.T. Lee, G.M. Air / Virology 345 (2006) 424–433 425NA complexed with two monoclonal antibodies, NC41 and
NC10. The 2.5 A˚ crystal structure of N9 NA complexed with
NC41 Fab shows 19 NA residues contacting 17 NC41 amino
acids (Colman et al., 1987; Tulip et al., 1992; Tulip et al.,
1989). Escape mutants selected with a panel of monoclonal
antibodies to the NA contained a single amino acid change,
located on the top of the NA near the rim of the active site
crater, except for one double mutant (Webster et al., 1987). The
amino acids on the NA that changed in escape mutants that
were no longer inhibited by NC41 were found to be directly in
contact with NC41. Of 19 escape mutants selected by NC41 in
independent experiments, ten were at residue 373, six at 368,
and two at 400. One escape mutant had two changes, at
residues 434 and 437 (Air et al., 1990).
Since there was such a limited number of positions where
escape mutants were selected, we hypothesized that the antibody
selection process may be very rigorous, with only changes in
residues crucial for the interaction being able to abolish binding
and allow escape from antibody inhibition (Air et al., 1990). This
was confirmed for the NC41 epitope by mutagenesis. Of the 19
residues of N9 NA that contact NC41, only the side chains of
Ser368, Asn400, and Lys434 were critical such that even the
most conservative changes abolished binding (Nuss et al., 1993).
The other sites of contact could accommodate at least some
substitutions with little effect on binding affinity, and mutations
could be similarly accommodated in the antibody paratope
(Pruett and Air, 1998).
We next investigated the complex between NA and antibody
NC10 and found that all the site-directed mutants we made were
inhibited by NC10 to the same extent as wild-type NA, although
with less affinity in most cases. Thus, the NC10 epitope can
accommodate a change at any site and is not dominated by a fewhigh-energy interactions as was found in the NC41 epitope. We
proposed that the difference was in the contribution of water
molecules buried in the interface of the NA–NC10 complex;
these water molecules may dissipate the individual interaction
energies so there are no critical contacts (Lee and Air, 2002). In
accord with this, escape mutants were difficult to select with
NC10 (Air et al., 1990; Webster et al., 1987).
While these results with an avian NA were interesting in
terms of protein structure, we questioned their relevance to
human influenza and we attempted to crystallize N2 NAs from
relatively recent human influenza viruses. Eventually, we were
successful with NA of a ‘‘Sydney-like’’ strain of influenza,
A/Memphis/31/98 (H3N2), and were able to crystallize this NA
J.T. Lee, G.M. Air / Virology 345 (2006) 424–433426complexed with the Fab of monoclonal antibody 6H3.2A11,
referred to as Mem5. We previously characterized escape
mutants selected with a panel of monoclonal antibodies against
Memphis/98 NA (Gulati et al., 2002) that recognized over-
lapping epitopes. The crystal structure of the complex has now
been refined to 2.1 A˚ (Venkatramani et al., submitted for
publication), allowing detailed analysis of the interactions
between NA and Fab. We have now determined the contribu-
tions to binding energy of the side chains in theMem5 epitope on
Mem/98 NA by analysis of mutations in the contacting amino
acids. We find that there are critical contacts at sites corres-
ponding to escape mutations, despite the presence of a large
number of water molecules in the interface. The critical contacts
are the most likely amino acids to mutate during antigenic drift,
thus determination of critical contacts allows prediction of
possible future directions of antigenic drift.
Results
Mutagenesis and expression of wild-type and mutant NA
The Mem/98 NA–Mem5 Fab complex (Venkatramani
et al., submitted for publication) is the first crystal structureFig. 2. Determination of Kd. Representative experiments in which NA activity (A
described in Materials and methods and the Kd calculated as the concentration of aavailable of an NA from a human influenza virus complexed
with antibody. The structure obtained is at high resolution
(2.1 A˚) compared with avian subtype N9 NA–antibody or
human influenza HA–antibody complexes. The high resolu-
tion and human virus NA gave us a unique opportunity to
test by mutagenesis the relative energy of the observed
hydrogen bonds and salt links and their relationship to
antigenic drift. We examined the crystal structure of the
complex between N2 NA and Mem5 Fab (Venkatramani
et al., submitted for publication) and designed mutations at
seven NA residues identified as having side chains that make
hydrogen bonds, van der Waals interactions, and/or salt
bridges with the Fab. The rationale for designing each
mutation is explained in Table 1. Wild-type and mutant
proteins were expressed in HeLa cells using the vaccinia
virus-T7 polymerase system (Fuerst et al., 1986).
Expression levels of wild-type and mutant proteins
appeared similar as seen by Western blot, but the antiserum
we had available was of low titer and we were unable to
quantitate the NA levels because standard curves were erratic
and there was a high background. The level of NA enzyme
activity in cell lysates was similar to wild-type for 11 of the
12 mutants, showing that the mutations do not affect the NA549) is plotted against Ag antibody in the reaction. The curves were fitted as
ntibody (nM) that gives 50% inhibition.
Table 2
Binding constants between antibody Mem5 and wild-type or mutant Mem/98
NA
NA Kd from inhibition
curve (nM)a
Kd from
ELISA (nM)b
Wild-type 10.9 T 3.9 11 T 6
D147A 20.9 T 5.4 13 T 7
D147N 23.5 T 7.5 13 T 7
H150A 14.9 T 5.7 5 T 3
H197A 18.1 T 2.5 10 T 5
D198A 16.5 T 3.8 19 T 10
D198N 14.3 T 4.6 3 T 2
E199A 234 T 20 >>c
E199Q 299 T 18 >>
K221R 114 T 18 63 T 32
A246K –d 14 T 7
D251N 19.2 T 3.1 23 T 12
D251A 19.1 T 5.8 29 T 15
a Average of 3–5 experiments T standard deviation.
b Based on the assumption that all mutants except A246K have the same
enzyme specific activity as wild-type NA. A246K has almost no enzyme
activity and was assumed to have a protein level similar to the others from the
observation that bands on a Western blot were similar for wild-type and all
mutants. The errors, due to inability to reliably measure NA protein from the
Western blot, are estimated as T50%.
c >> means Kd is too high to fit the curve or even estimate.
d Mutant A246K was enzymatically inactive.
Fig. 3. ELISA to measure binding of wild-type and mutant NAs to antibody
Mem5. The plates were coated with antibody and titrated with the cell lysates.
Bound NA was detected with a human anti-N2 NA antiserum and anti-human
IgG conjugated with alkaline phosphatase. The plates were read at 405 nm.
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proteins were expressed at approximately the same levels.
The exception was mutant A246K, which reacted with
Mem5 monoclonal antibody in ELISA but had barely
detectable NA enzyme activity. Mem5 antibody does not
react with unfolded NA, so this result indicated that the
A246K protein was folded correctly but had some distur-
bance to the active site.
Kd of wild-type or mutant NA measured by enzyme inhibition
Antibodies against NA prevent the spread of virus by
inhibiting NA activity, and escape mutants selected by anti-
NA antibodies are found to have NA mutations such that they
are no longer inhibited by antibody. Therefore, we first
determined Kd by measuring antibody inhibition of NA enzyme
activity. An amount of detergent-treated cell lysate that gave an
absorbance (A549) of approximately 1.0 in the standard NA
assay was titrated with increasing amounts of purified Mem5
antibody. Mem5 inhibited the wild-type NA activity up to 90%,
and most of the mutant NAs were inhibited to within 5% of
wild-type NA (Fig. 1). However, K221R, E199A, and E199Q
show low or undetectable levels of inhibition by the antibody.
The inhibition curves could be fitted to a polynomial equation
with reasonable statistics. The Kd was obtained from the curve
fits as the concentration of antibody at which inhibition of
activity is 50%. A sample curve fit of each mutant is shown in
Fig. 2. The Kds from 3 to 5 experiments were averaged and are
shown for the detergent-solubilized wild-type and mutant NAs
in Table 2. The binding constant for K221R is approximately 10
times higher than wild-type NA, while the values for E199A
and E199Q are 20–30 times higher.Kd of wild-type or mutant NA measured by ELISA
Failure of antibody inhibition in a mutant does not
necessarily mean that the antibody does not bind; it was
possible that antibody in this assay bound to the mutants in
an altered way such that it no longer inhibited NA activity
as was shown crystallographically for an N9 mutant that
was bound by antibody NC41 but not inhibited (Tulip et al.,
1989). We therefore used an ELISA to test if inhibition of
NA by Mem5 antibody is a reflection of the degree of
binding of mutant NA by the antibody. Since the antiserum
available was too weak to use Western blot to quantitate the
amount of NA protein, we made the assumption that the
specific activities are the same for mutant and wild-type
NA, as found in our previous studies (Lee and Air, 2002;
Nuss et al., 1993) and calculated the amount of protein from
the level of enzyme activity, standardizing this with purified
wild-type NA. The concentration of wild-type or mutant NA
protein in the lysates estimated on this basis ranged between
0.1 and 0.2 nmol/ml, in accord with the similar band
intensities seen on the Western blot. The results are shown
in Fig. 3. For all of the enzymatically active mutants, there
is a correlation between inhibition of NA activity and
binding by antibody. Mutant K221R bound very weakly,
and E199A/Q did not bind at all. Mutant A246K has no
enzyme activity but binds quite well in ELISA (Fig. 3), so
we assigned it a concentration at the mid-point of the range.
The Kds derived from the ELISA are not precise due to the
assumption that the specific activities are equal, but they do
not show any discrepancy when compared with the Kds
obtained from enzyme inhibition curves (Table 2). Nine
mutants have Kds similar to wild-type NA, while 3 mutants
(E199A, E199Q, K221R) do not bind to Mem5 antibody
and are not inhibited by it.
These findings show there are a few critical contacts in
the Mem5 epitope on Mem/98 NA, as found for the NC41
epitope (Nuss et al., 1993) but unlike those of the NC10
epitope (Lee and Air, 2002).
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From a study of the crystal structure of the complex between
antibody D1.3 or HyHEL-5 and hen egg lysozyme, Novotny
and coworkers proposed that only a small number of amino
acids contribute actively to binding energetics (Novotny, 1991;
Novotny et al., 1989). This concept of an ‘‘energetic epitope’’
was experimentally demonstrated for the complex of influenza
N9 NA and NC41 Fab (Nuss et al., 1993) and similar
energetically dominant amino acids that had been identified
in several other complexes (Huang et al., 1998; Schreiber and
Fersht, 1996; Wells, 1996). However, we found that this was
not the case when N9 NA was complexed with another
antibody (NC10) that has an epitope on N9 NA that overlaps
that of NC41 (Lee and Air, 2002). In the NA–NC10 complex,
mutation analysis suggested that the energy was distributed
over the interface, and we proposed that water molecules
trapped in the interface might be mediating this distribution. To
further investigate the effect of buried water on an energetic
epitope and its relevance in antigenic drift, we have studied
mutations in an epitope on a recent human NA of a different
subtype (N2).
Apparent Kds of wild-type and mutant NAs
The Kd we determined for expressed wild-type N2 NA
using inhibition of enzyme activity is 11 nM. All of the
mutants showed lower affinity, the majority having a Kd of
14–20 nM. The exceptions, with markedly lower affinity for
antibody, were K221R (114 nM) and E199A and E199Q
(234 nM and 299 nM respectively). The ELISA showed the
same trend in binding affinities among the mutants. The Kd
for wild-type NA binding to Mem5 is similar to those
reported for N9 NA antibody complexes, reviewed previ-
ously (Lee and Air, 2002).
We made mutations in amino acids that have side chains in
contact with antibody (Venkatramani et al., 2006), focusing on
those that are involved in salt bridges and hydrogen bonds:
D147, H150, H197, D198, E199, K221, D251, with one van
der Waals contact, A246. We made replacements that change
the side chain to either one of similar size with different
properties or to alanine that potentially creates a cavity as well
as eliminating polar interactions.
Effects of reducing side chain size to Ala: D147A, H150A,
H197A, D198A, E199A, D251A
The side chains targeted are all on the surface of the NA, so
we did not expect disturbance to NA structure due to instability
of internal cavities. There might, however, be cavities formed
in the NA–Fab interface, increasing the Kd. For all but one of
the mutants, there was indeed a small increase in the Kd
measured by enzyme inhibition, but of borderline significance
(Table 2). The exception was E199A. Since E199Q was
similarly disruptive to binding, it is likely that the loss of the
salt link to antibody is more important than the potential
existence of a buried cavity. Matthews showed for T4lysozyme that such cavities tend to be stabilized by trapping
of water molecules (Eriksson et al., 1992). H150 also
participates in a salt link to the antibody, but we conclude that
this is of low energy since elimination of that salt link had little
or no effect on antibody binding.
Effect of substituting a larger side chain: A246K
Mutant 246 bound to Mem5 antibody in ELISA with an
affinity similar to wild-type NA. Since Mem5 is conformation-
specific and binding involves several loops of polypeptide, the
ELISA result indicates that the mutant NAwas folded correctly.
However, the mutant lost NA activity to a level that was barely
detectable and which precluded inhibition assays. The loss of
enzyme activity was somewhat surprising since A246 is on the
surface of the NA with Ch pointing outwards. We thought that
the addition of a Lys side chain might interfere with antibody
binding but did not expect it to affect other properties of the
NA. The explanation might be that the lysine side chain could
interact with the nearby E276, pulling it from its normal
interactions with R224. E276 and R224 both bind to sialic acid
in the NA catalytic site, and we have shown that E276 is
critical for enzyme activity (Ghate and Air, 1998).
Effects of changing charged or polar side chains: D147N,
D198N, E199Q, D251N, K221R
Replacement of a charged side chain with a polar one at
D147 or even a non-polar one in H150A had only a small effect
on antibody binding or inhibition, even though these residues
participate in salt links to the antibody H chain. The carboxyl
Oy1 of D251 is hydrogen-bonded to Y53 hydroxyl of the
antibody L chain, and Oy2 participates in water-mediated
hydrogen bonds to antibody. These direct and water-mediated
hydrogen bonds are likely to be maintained in D251N, so it is
not surprising that the Kd measured by inhibition is only
slightly increased (Table 2). However, the effect on Kd of
removing the hydrogen bonding potential completely in
D251A was only two-fold, suggesting that these are all low-
energy hydrogen bonds.
D198 is interesting in that it potentially forms two ‘‘long’’
hydrogen bonds to antibody, outside the 3.4 A˚ maximum
distance used in defining hydrogen bonds, and it also
participates in water-mediated hydrogen bonds to antibody
(Venkatramani et al., submitted for publication). There was a
slight increase in Kd for D198N as measured by inhibition, but
binding was increased (Kd decreased) when measured by
ELISA, even taking the uncertainties of NA concentration into
account. This difference suggests that the direct hydrogen
bonds might be more stable in the mutant than in wild-type
NA. The decreased binding of D198A, with no hydrogen
bonding potential, supports this idea. Antibodies had selected
NA escape mutants in which D198 had been changed to Val
(Gulati et al., 2002). These mutants had low enzyme activity,
suggesting that there is a steric disruption of the structure by
Val. The mutants D198N and D198A had normal levels of
enzyme activity.
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found with K221R and E199Q or A. Both of these sites were
selected in escape mutants, giving E199G or V or K221E or N
(Gulati et al., 2002). The more conservative changes made by
mutagenesis are just as disruptive to antibody binding. The (-
amino group of K221 forms three hydrogen bonds to antibody,
one to light chain (Tyr L49 O) and two to heavy chain (Thr
H99 Og and Asn H100 Oy1). Apparently, the different
configuration and distance of the guanidino group in Arg
cannot substitute for the Lys amino group. We have found
similar large effects of a Lys/Arg substitution, which is usually
described as ‘‘conservative’’, in other mutagenesis studies as
well as in escape mutants (Ghate and Air, 1998; Nuss et al.,
1993). E199 makes multiple interactions with antibody, but all
these hydrogen bonds could potentially also be made with
E199Q. Thus, we conclude that the salt link of E199 to
antibody H chain R52 contributes the most energy to the NA–
Fab interaction.
Why is the E199 salt link more important than others?
In previous studies of epitopes on N9 NA, we found that
there were three residues on NA that provided most of the
binding energy to antibody NC41 but that the energy was
dispersed in the NC10 epitope. We hypothesized that the
difference was due to the presence of water molecules in the
NC10 interface (Lee and Air, 2002). The crystal structure of
Mem/98 NA complexed with Mem5 antibody shows 33 water
molecules buried in the interface, creating an intricate network
of hydrogen bonds that connect antigen with antibody, in
addition to the direct interactions (Venkatramani et al., 2006).
We were therefore surprised to find that K221 and especially
E199 behave as critical contacts in the interaction, and we have
looked more closely at the role of water in the Mem/98 NA–
Mem5 complex structure.
Water is a highly versatile contributor to the interaction
between proteins. Due to its tetrahedral coordination, it can
serve as both hydrogen bond donor and acceptor, although it
tends to act as a donor more due to the most frequent side
chains for hydration being those of Asp and Glu. There are few
steric constraints on bond formation, and water can participate
in multiple hydrogen bonds, often making at least three
(Poornima and Dean, 1995b). As well as water molecules that
actually bridge two proteins, some water molecules may
stabilize the complex by holding those that do bridge in the
right position. Water can also make hydrogen bonding
arrangements that are not greatly affected by binding of the
ligand. Ladbury noted that conserved bound water molecules
have highly favorable hydrogen bonds lengths, positioning,
and electrostatic and Lennard–Jones potentials (Ladbury,
1996). The mobilities (B-factors) of bound water molecules
are often similar to those of the protein atoms that bind them
(Poornima and Dean, 1995b). Bound water molecules can
determine substrate specificity, modifying the shape and
complementarity of the sites where they are bound (Quiocho
et al., 1989). Mutations designed to destabilize a protein by
introducing internal cavities often have little effect becausewater fills the pockets created and provides the hydrogen
bonding capacity of the deleted side chain (Eriksson et al.,
1992; Vaughan et al., 1999).
A paradigm that water will be displaced when proteins bind
to their ligands has been reevaluated as more high-resolution
structures became available. In one study of 26 complexes,
most water molecules were seen to be retained on complex
formation (Poornima and Dean, 1995a). Of 30 high-resolution
antibody complexes, most contained water molecules in the
interface (Sundberg and Mariuzza, 2003). Water molecules
appear to be required to improve the fit between interacting
proteins and to neutralize unpaired hydrogen-bonding groups.
This flexibility of water compensates for the lack of evolu-
tionary optimization in antigen–antibody interfaces as com-
pared to that found in other protein–protein interfaces (Bhat
et al., 1994; Kondo et al., 1999; Li et al., 2000; Mylvaganam
et al., 1998; Sundberg and Mariuzza, 2003). In the complex
between FvD1.3 and hen egg lysozyme, CDR3 of the Fv VH
actually undergoes a conformational change to bring more
antibody-bound water molecules into contact with the antigen
(Bhat et al., 1994).
Although water can play an important role in stabilizing
protein interactions, there is also evidence that an amino acid
side chain needs to be excluded from solvent to make a high-
energy critical contact. The intermolecular packing between
human growth hormone and its receptor is in general closer at
the critical residues than at the unimportant ones (Clackson and
Wells, 1995). A substitution of Phe for Tyr in a macrolide
binding protein unexpectedly resulted in stronger binding. The
structures of the bound wild-type and mutant proteins were
virtually identical except for the removal of two water
molecules. Ultimately, it was concluded that, despite the less
favorable enthalpy change which resulted from removal of
polar atoms from water, the entropic advantage of removing
water molecules led to a slightly more favorable change in the
overall free energy of binding (Connelly et al., 1994).
Similarly, a particularly potent inhibitor of glycogen phosphor-
ylase b showed increased binding in part due to an increase in
entropy from displacement of a water molecule (Watson and
Papageorgiou, 1994).
A study of mutations in human lysozyme showed that the
contribution of a salt bridge to protein stability is inversely
related to its accessibility to water (Takano et al., 2000). This is
because electrostatic interactions are affected by the dielectric
constant, and this in turn differs greatly between the interior
and surface of a protein (Tanford and Roxby, 1972). A salt
bridge that is highly exposed to solvent contributes little to
protein stability. In contrast, a salt bridge that is 100%
inaccessible contributes approximately 9 kJ/mol, which is the
contribution of a salt bridge in the interior of the proteins
(Pervushin et al., 1996; Tissot et al., 1996). This finding
reconciles a number of conflicting reports on the issue and also
helps explain the stability of thermophilic proteins.
In the Mem/98 NA–Mem5 Fab complex, there are three salt
bridges between Mem/98 NA and the antibody, involving
D147, H150, and E199. Our results of binding assays on
mutant NA proteins show that the salt bridges made by D147
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complex. However, we conclude that E199 is a critical contact
because mutation to either glutamine or alanine resulted in
abrogation of binding of mutant NA to antibody. Areaimol
(Collaborative Computational Project, 1994) calculates the
accessible surface area of individual side chains in NA and Fab
individually and as the complex. The buried surface area is the
loss in accessible surface after complex formation, expressed as
a percentage of the uncomplexed accessible surface. D147 and
H150 are 63% and 87% buried, respectively, in the antigen–
antibody interface on formation of the complex (Venkatramani
et al., 2006) and so do not meet the criterion for ‘‘buried’’,
which is 5% exposed to bulk solvent (Janin et al., 1988).
D147 is hydrogen-bonded to two water molecules that are
part of the extensive network in the interface. The imidazole
ring of H150 is not directly hydrogen-bonded to water
molecules, but the imidazole N atoms contact D147 and
D31(VH) and thus connect H150 to the water network (Fig.
4A). Therefore, we can conclude that the lack of effect of
mutations that remove the D147 and H150 salt bridges is a
combination of exposure to bulk solvent at the surface and to
the water network in the interface. In contrast to these, E199
is 100% buried from bulk solvent by complex formation and
is isolated from the interfacial water network (Fig. 4B). K221Fig. 4. Isolation of E199 from water. (A) The charged interactions of D147 and
H150 with antibody are connected to the water hydrogen-bonded network. (B)
In contrast, there are no water molecules within hydrogen bonding distance of
E199 or any of its interacting partners on the H chain. Dashed lines indicate
hydrogen bonds and salt links, green spheres are water molecules, sized
according to their distance above or below the main plane of the interactions.
Figures were drawn from Swiss PDB Viewer (Glaxo).is similarly 100% buried in the interface and isolated from
water molecules. The amino group participates in hydrogen
bonding, but there is no acidic group in the vicinity to
neutralize its charge.
The N9 NA–NC41 interaction showed three critical
contacts at which even the most conservative change on NA
eliminated antibody binding (Nuss et al., 1993). At the
resolution obtained of 2.5 A˚, no water molecules were seen
in the interface, and it appeared that all contacts were shielded
from water (Tulip et al., 1992). The N9 NA–NC10 complex
did not have any critical contacts (Lee and Air, 2002), and there
are a few water molecules buried in the interface. The results
reported here show that the Mem/98 N2 NA–Mem5 Fab
complex has two critical contacts, E199 and K221. Although
there are a large number of water molecules in the interface of
this complex, both critical residues are excluded from solvent.
Thus, it appears that high-energy hydrogen bonds as well as
salt bridges are dependent on isolation from trapped water
molecules in addition to burial from bulk solvent.
Since avian influenza viruses do not undergo progressive
antigenic drift in the same way as human viruses, we were
not able to use our results from N9 NA mutagenesis
experiments to test our hypothesis that antigenic drift is
likely to occur at critical contacts and that therefore a low
number of critical contacts may allow prediction of future
directions of antigenic drift. With human N2, we can now
examine sequences of NA isolated since 1998 for changes in
the critical contacts. Although the Mem5 epitope is defined
by a mouse monoclonal antibody, it has proved to be highly
significant in human influenza since both the critical amino
acids, E199 and K221, as well as two other contacts to
Mem5, have mutated in human H3N2 viruses isolated up to
2005 (Macken et al., 2001; Venkatramani et al., 2006). Thus,
identification of critical contacts in a dominant epitope may
help to identify the best candidate strains for future influenza
vaccines since these will have changes in the critical
contacts.
Materials and methods
Viruses and cells
The NA-minus virus NWS-Mvi was used to make a
reassortant virus that has the HA of A/NWS/33 and the NA
of A/Mem/98. This virus was designated NWS-Mem/98
(Gulati et al., 2002) and was the source of the protein used
for X-ray crystallography and the gene that we cloned. Virus
was grown in MDCK cells in serum-free medium. For transient
expression of proteins, HeLa cells were grown in DMEM
containing 10% supplemented calf serum (HyClone), 1%
glutamine, 1% sodium pyruvate, 1% kanamycin sulfate, and
1% penicillin/streptomycin.
Antibodies
Production, purification, testing, and sequencing of Mem5
antibody have been described (Gulati et al., 2002). A
J.T. Lee, G.M. Air / Virology 345 (2006) 424–433 431convalescent serum from an individual who had a confirmed
influenza infection was also used.
Mutagenesis and protein expression
The NA gene of Mem/98 was amplified by reverse
transcriptase-PCR and cloned into the vector Bluescript
downstream of the T7 promoter. Mutations were made using
the Chameleon Double-Stranded Site-Directed Mutagenesis
Kit (Stratagene). The mutant NA genes were sequenced to
determine the desired mutations, and no others, were present,
then transfected into confluent HeLa cells infected with the
recombinant vaccinia virus vvTF7-3 (Lee and Air, 2002). The
vvTF7-3 virus encodes T7 RNA polymerase, allowing
expression of the wild-type or mutant NA genes with high
efficiency (Fuerst et al., 1986). Influenza NA cannot be
expressed in native form in E. coli or other high-yield systems,
and so we used the methods developed to quantitate the activity
and antibody binding of mutant NAs expressed on a
mammalian cell surface (Ghate and Air, 1998; Lee and Air,
2002).
Stratagene’s QuikChange XL Site-Directed Mutagenesis Kit
was used to mutagenize NA genes. Mutagenic oligonucleotides
and their complementary oligonucleotides were named accord-
ing to the original amino acid, its position, and the residue to
which it is changed; the bases responsible for the change are
underlined. The following oligonucleotides and their comple-
mentary oligonucleotides were used:
D147A, 5V-CAACAGGCATTCAAATGCCACAGTGCATGA-
TAGGACCCC-3VD147ACOMP, 5V-GGGGTCCTATCATGCACTGTGGCATTT-
GAATGCCTGTTG-3VD147N, 5V-CAACAGGCATTCAAATAACACAGTGCAT-
GATAGGACCCC-3VD147NCOMP, 5V-GGGGTCCTATCATGCACTGTGTTATTT-
GAATGCCTGTTG-3VH150A, 5V-GGCATTCAAATGACACAGTGGCTGATAG-
GACCCCTTATCGAACCC-3VH150ACOMP, 5V-GGGTTCGATAAGGGGTCCTATCAGC-
CACTGTGTCATTTGAATGCC-3VH197A, 5V-GGCTGCATGTTTGTGTAACTGGGGCTGAT-
GAAAATGCAACTGC-3VH197ACOMP, 5V-GCAGTTGCATTTTCATCAGCCCCAGT-
TACACAAACATGCAGCC-3VD198A, 5V-CATGTTTGTGTAACTGGGCATGCCGAAAAT-
GCAACTGCTAGC-3VD198ACOMP, 5V-GCTAGCAGTTGCATTTTCGGCATGCC-
CAGTTACACAAACATG-3VD198N, 5V-CATGTTTGTGTAACTGGGCATAACGAAAA-
TGCAACTGCTAGC-3VD198NCOMP, 5V-GCTAGCAGTTGCATTTTCGTTATGCCC-
AGTTACACAAACATG-3VE199A, 5V-GTTTGTGTAACTGGGCATGATGCGAATGCA-
ACTGCTAGCTTC-3VE199ACOMP, 5V-GAAGCTAGCAGTTGCATTCGCATCAT-
GCCCAGTTACACAAAC-3VE199Q, 5V-GTTTGTGTAACTGGGCATGATCAGAATGCA-
ACTGCTAGCTTC-3VE199QCOMP, 5V-GAAGCTAGCAGTTGCATTCTGATCAT-
GCCCAGTTACACAAAC-3VK221R, 5V-GTATTGGTTCATGGTCCAAAAGAATCCTCA-
GGACCCAGGAGTCGG-3VK221RCOMP, 5V-CCGACTCCTGGGTCCTGAGGATTCTT-
TTGGACCATGAACCAATAC-3VA246K, 5V-GGAACTTGTACAGTAGTAATGACTGATGGG-
AGTAAGTCAGGAAGAGCTG-3VA246KCOMP, 5VCAGCTCTTCCTGACTTACTCCCATCAGQ
TCATTACTACTGTACAAGTTCC-3VD251A, 5V-GGGAGTGCTTCAGGAAGAGCTGCCACTAA-
AATACTATTCATTGAG-3VD251ACOMP, 5V-CTCAATGAATAGTATTTTAGTGGCAGC-
TCTTCCTGAAGCACTCCC-3VD251N, 5V-GGGAGTGCTTCAGGAAGAGCTAACAC-
TAAAATACTATTCATTGAG-3VD251NCOMP, 5V-CTCAATGAATAGTATTTTAGTGTTAGC-
TCTTCCTGAAGCACTCCC-3V.All mutants were sequenced over the full NA coding region
using an ABI/Prism DNA Sequencer with dye-labeled termi-
nators. The oligonucleotide primers used were:
Tok308, 5V-TTTGCACCTTTTTCTAAGG-3V
Mem98NA825, 5V-CAGCCCACTGTCAGGAAGTGCTCAG-CATGTCGAGGAATGCTCC-3V
M13For, 5V-GTAAAACGACGGCCAGTG-3V.
Neuraminidase inhibition (NI) assays
An amount of lysate containing wild-type or mutant NA
that released about 30 nmol of sialic acid from fetuin after
30 min incubation in the standard NA assay (Lee and Air,
2002) was titrated with Mem5 antibody. Each lysate was
preincubated with 3 AM to 77 AM purified Mem5 antibody
for 5 min before adding fetuin substrate. The colorimetric
readings (A549) were plotted against Ag of Mem5, the
resulting curve fitted using the polynomial fit in Microsoft
Excel, and the Kd derived as the concentration of ligand at
which the receptor is half-saturated. The Kds from 3 to 5
experiments were averaged.
Enzyme-linked immunosorbent assay (ELISA)
Binding of Mem5 antibody to N2 NA was analyzed by
ELISA as previously described (Lee and Air, 2002). The wells
of a 96-well microtiter plate were coated with Mem5 antibody
(10 Ag/ml in carbonate/bicarbonate coating buffer, 50 Al per
well), incubated at 4 -C overnight, and washed three times with
phosphate-buffered saline (8 g NaCl, 0.2 g KH2PO4, 2.9 g
Na2HPO4I12H2O, 0.2 g KCl, and 0.2 g NaN3 in 1 l H2O, pH
7.4) containing 0.05% Tween. Nonspecific binding was
blocked with 2% dry milk in PBS (100 Al per well). After
washing, individual cell lysates containing wild-type and
mutant NA were added in 2-fold serial dilutions and incubated
J.T. Lee, G.M. Air / Virology 345 (2006) 424–433432for 4 h at 37 -C. This was followed after washing by addition
of anti-N2 NA human antiserum (diluted 1:1000 in 1% dry
milk, 50 Al in each well) and incubated for 4 h at 37 -C. Anti-
human IgG conjugated with alkaline phosphatase was then
added (diluted 1:1000 in 1% dry milk, 50 Al per well). Finally,
Sigma 104 phosphatase substrate was added (1 mg/ml in
diethanolamine buffer, 50 Al per well) and incubated until
sufficient color had developed (approximately 20 min); then
the absorbance was read at 405 nm. The results were fitted to
the binding equation using Kaleidagraph (Synergy), which
gave the Kds (Gulati et al., 2005).
Acknowledgments
The authors are indebted to Lalitha Venkatramani for
providing the purified Mem5 monoclonal antibody and the
coordinates of the crystal structure of Mem5 complexed with
A/Mem/31/98 NA. We thank Alexey Botchkarev and Adam
Zlotnick for insight into the structure of the complex. The work
was supported by grant AI50933 from NIAID and institutional
training grant T32 AI07633 (J.L.).
References
Air, G.M., Laver, W.G., 1989. The neuraminidase of influenza virus (review).
Proteins 6, 341–356.
Air, G.M., Laver, W.G., Webster, R.G., 1990. Mechanism of antigenic variation
in an individual epitope on influenza virus N9 neuraminidase. J. Virol. 64,
5797–5803.
Bhat, T.N., Bentley, G.A., Boulot, G., Greene, M.I., Tello, D., Dall’Acqua, W.,
Souchon, H., Schwarz, F.P., Mariuzza, R.A., Poljak, R.J., 1994. Bound
water molecules and conformational stabilization help mediate an antigen–
antibody association. Proc. Natl. Acad. Sci. U.S.A. 91, 1089–1093.
Bizebard, T., Gigant, B., Rigolet, P., Rasmussen, B., Diat, O., Bosecke, P.,
Wharton, S.A., Skehel, J.J., Knossow, M., 1995. Structure of influenza
virus haemagglutinin complexed with a neutralizing antibody. Nature 376,
92–94.
Clackson, T., Wells, J.A., 1995. A hot spot of binding energy in a hormone–
receptor interface. Science 267, 383–386.
Collaborative Computational Project, 1994. The CCP4 suite: programs for
protein crystallography. Acta Crystallogr., Sect. D: Biol. Crystallogr. 50,
760–763.
Colman, P.M., Laver, W.G., Varghese, J.N., Baker, A.T., Tulloch, P.A., Air,
G.M., Webster, R.G., 1987. Three-dimensional structure of a complex of
antibody with influenza virus neuraminidase. Nature 326, 358–363.
Connelly, P.R., Aldape, R.A., Bruzzese, F.J., Chambers, S.P., Fitzgibbon, M.J.,
Fleming, M.A., Itoh, S., Livingston, D.J., Navia, M.A., Thomson, J.A.,
Wilson, K.P., 1994. Enthalpy of hydrogen bond formation in a protein–
ligand binding reaction. Proc. Natl. Acad. Sci. U.S.A. 91, 1964–1968.
Eriksson, A., Baase, W., Zhang, X., Heinz, D., Blaber, M., Baldwin, E.,
Matthews, B., 1992. Response of a protein structure to cavity-creating
mutations and its relation to the hydrophobic effect. Science 255,
178–183.
Fleury, D., Barrere, B., Bizebard, T., Daniels, R.S., Skehel, J.J., Knossow,
M., 1999. A complex of influenza hemagglutinin with a neutralizing
antibody that binds outside the virus receptor binding site. Nat. Struct.
Biol. 6, 530–534.
Fuerst, T.R., Niles, E.G., Studier, F.W., Moss, B., 1986. Eukaryotic transient-
expression system based on recombinant vaccinia virus that synthesizes
bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. 83, 8122–8126.
Ghate, A.A., Air, G.M., 1998. Site-directed mutagenesis of catalytic residues of
influenza virus neuraminidase as an aid to drug design. Eur. J. Biochem.
258, 320–331.Gulati, U., Hwang, C.-C., Venkatramani, L., et al., 2002. Antibody epitopes on
the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98). J.
Virol. 76, 12274–12280.
Gulati, U., Kumari, K., Wu, W., Keitel, W.A., Air, G.M., 2005. Amount and
avidity of serum antibodies against native glycoproteins and denatured virus
after repeated influenza whole-virus vaccination. Vaccine 23, 1414–1425.
Huang, M., Syed, R., Stura, E.A., Stone, M.J., Stefanko, R.S., Ruf, W.,
Edgington, T.S., Wilson, I.A., 1998. The mechanism of an inhibitory
antibody on TF-initiated blood coagulation revealed by the crystal
structures of human tissue factor, Fab 5G9, and TF.G9 complex. J. Mol.
Biol. 275, 879–894.
Janin, J., Miller, S., Chothia, C., 1988. Surface, subunit interfaces and interior
of oligomeric proteins. J. Mol. Biol. 204, 155–164.
Kondo, H., Shiroishi, M., Matsushima, M., Tsumoto, K., Kumagai, I., 1999.
Crystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10)
Fv–antigen complex. Local structural changes in the protein antigen and
water-mediated interactions of Fv-antigen and light chain–heavy chain
interfaces. J. Biol. Chem. 274, 27623–27631.
Ladbury, J.E., 1996. Just add water! The effect of water on the specificity of
protein– ligand binding sites and its potential application to drug design.
Chem. Biol. 3, 973–980.
Lee, J.T., Air, G.M., 2002. Contacts between influenza N9 neuraminidase and
monoclonal antibody NC10. Virology 300, 255–268.
Li, Y., Li, H., Smith-Gill, S.J., Mariuzza, R.A., 2000. Three-dimensional
structures of the free and antigen-bound Fab from monoclonal antilysozyme
antibody HyHEL-63. Biochemistry 39, 6296–6309.
Liu, C., Eichelberger, M.C., Compans, R.W., Air, G.M., 1995. Influenza type A
virus neuraminidase does not play a role in viral entry, replication,
assembly, or budding. J. Virol. 69, 1099–1106.
Macken, C., Lu, H., Goodman, J., Boykin, L., 2001. The value of a database in
surveillance and vaccine selection. In: Osterhaus, A., Cox, N., Hampson, A.
(Eds.), Options for the Control of Influenza IV. Elsevier, Amsterdam,
pp. 103–106.
Mylvaganam, S.E., Paterson, Y., Getzoff, E.D., 1998. Structural basis for the
binding of an anti-cytochrome c antibody to its antigen: crystal structures of
FabE8–cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A
resolution. J. Mol. Biol. 281, 301–322.
Novotny, J., 1991. Protein antigenicity: a thermodynamic approach. Mol.
Immunol. 28, 201–207.
Novotny, J., Bruccoleri, R.E., Saul, F.A., 1989. On the attribution of binding
energy in antigen–antibody complexes McPC603, D1.3 and HyHEL-5.
Biochemistry 28, 4735–4749.
Nuss, J.M., Whitaker, P.B., Air, G.M., 1993. Identification of critical contact
residues in the NC41 epitope of a subtype N9 influenza virus neura-
minidase. Proteins 15, 121–132.
Palese, P., Tobita, K., Ueda, M., Compans, R.W., 1974. Characterization of
temperature sensitive influenza virus mutants defective in neuraminidase.
Virology 61, 397–410.
Pervushin, K., Billeter, M., Siegal, G., Wuthrich, K., 1996. Structural role of a
buried salt bridge in the 434 repressor DNA-binding domain. J. Mol. Biol.
264, 1002–1012.
Poornima, C.S., Dean, P.M., 1995a. Hydration in drug design. 2. Influence of
local site surface shape on water binding. J. Comput.-Aided Mol. Des. 9,
513–520.
Poornima, C.S., Dean, P.M., 1995b. Multiple hydrogen-bonding features of
water molecules in mediating protein– ligand interactions. J. Comput.-
Aided Mol. Des. 9, 500–512.
Pruett, P.S., Air, G.M., 1998. Critical interactions in binding antibody NC41 to
influenza N9 neuraminidase: amino acid contacts on the antibody heavy
chain. Biochemistry 37, 10660–10670.
Quiocho, F.A., Wilson, D.K., Vyas, N.K., 1989. Substrate specificity and
affinity of a protein modulated by bound water molecules. Nature 340,
404–407.
Schreiber, G., Fersht, A.R., 1996. Rapid, electrostatically assisted association of
proteins. Nat. Struct. Biol. 3, 427–431.
Sundberg, E., Mariuzza, R., 2003. Molecular recognition in antibody–antigen
complexes. Adv. Protein Chem. 61, 119–160.
Takano, K., Tsuchimori, K., Yamagata, Y., Yutani, K., 2000. Contribution of
J.T. Lee, G.M. Air / Virology 345 (2006) 424–433 433salt bridges near the surface of a protein to the conformational stability.
Biochemistry 39, 12375–12381.
Tanford, C., Roxby, R., 1972. Interpretation of protein titration curves.
Application to lysozyme. Biochemistry 11, 2192–2198.
Tissot, A.C., Vuilleumier, S., Fersht, A.R., 1996. Importance of two buried salt
bridges in the stability and folding pathway of barnase. Biochemistry 35,
6786–6794.
Tulip, W.R., Varghese, J.N., Webster, R.G., Air, G.M., Laver, W.G., Colman,
P.M., 1989. Crystal structures of neuraminidase–antibody complexes. Cold
Spring Harbor Symp. Quant. Biol. 54, 257–263.
Tulip, W.R., Varghese, J.N., Laver, W.G., Webster, R.G., Colman, P.M., 1992.
Refined crystal structure of the influenza virus N9 neuraminidase–NC41
Fab complex. J. Mol. Biol. 227, 122–148.
Varghese, J.N., Laver, W.G., Colman, P.M., 1983. Structure of the influenza
virus glycoprotein antigen neuraminidase at 2.9 A resolution. Nature 303,
35–40.
Vaughan, C.K., Buckle, A.M., Fersht, A.R., 1999. Structural response to
mutation at a protein–protein interface. J. Mol. Biol. 286, 1487–1506.Venkatramani, L., Bochkareva, E., Lee, J.T., Gulati, U., Laver, W.G.,
Bochkarev, A., Air, G.M., 2006. An epidemiologically significant
epitope of a 1998 human influenza virus neuraminidase forms a highly
hydrated interface in the NA–antibody complex. J. Mol. Biol. 356,
651–663.
Watson, K.A., Papageorgiou, A., 1994. Design of inhibitors of glycogen
phosphorylase: a study of a- and h-C-Glucosides and 1-thio-h-d-glucose
compounds. Biochemistry 33, 5745–5758.
Webster, R.G., Air, G.M., Metzger, D.W., Colman, P.M., Varghese, J.N., Baker,
A.T., Laver, W.G., 1987. Antigenic structure and variation in an influenza
N9 neuraminidase. J. Virol. 61, 2910–2916.
Webster, R.G., Reay, P.A., Laver, W.G., 1988. Protection against lethal
influenza with neuraminidase. Virology 164, 230–237.
Wells, J.A., 1996. Binding in the growth hormone receptor complex. Proc. Natl.
Acad. Sci. U.S.A. 93, 1–6.
Wiley, D.C., Wilson, I.A., Skehel, J.J., 1981. Structural identification of the
antibody-binding sites of Hong Kong influenza haemagglutinin and their
involvement in antigenic variation. Nature 289, 373–378.
